ReviewFrontiers in immunology2018

Adoptive T Cell Therapy for Epstein-Barr Virus Complications in Patients With Primary Immunodeficiency Disorders.

Lauren P McLaughlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.